1h Free Analyst Time
The in-vitro toxicity testing market is forecasted to grow by USD 8.19 billion during 2024-2029, accelerating at a CAGR of 11.7% during the forecast period. The report on the in-vitro toxicity testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing use of in-vitro toxicity testing by companies to reduce drug failures, presence of toxic substances, and growth in government initiatives related toxicology testing.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The in-vitro toxicity testing market is segmented as below:
By End-user
- Pharmaceutical companies
- Academic and research institutions
- Others
By Type
- Cytotoxicity testing
- Genotoxicity testing
- Organ-specific toxicity testing
- Phototoxicity testing
- Dermal toxicity testing
By Technology
- Cell culture technology
- High throughput screening
- OMICS technology
- Computational toxicology
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the in-vitro toxicity testing market covers the following areas:
- In-Vitro Toxicity Testing Market sizing
- In-Vitro Toxicity Testing Market forecast
- In-Vitro Toxicity Testing Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Type
10 Market Segmentation by Technology
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global in-vitro toxicity testing market: Abbott Laboratories, Agilent Technologies Inc., Aragen Life Sciences Pvt. Ltd., Bio Rad Laboratories Inc., BioIVT LLC, Catalent Inc., Charles River Laboratories International Inc., Creative Bioarray, Creative Biolabs, Eurofins Scientific SE, Evotec SE, Gentronix Ltd., InSphero AG, Laboratory Corp. of America Holdings, MB Research Labs, Merck KGaA, Promega Corp., SGS SA, Thermo Fisher Scientific Inc., and XENOMETRIX AG.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advances in toxicology."
According to the report, one of the major drivers for this market is the increasing use of in-vitro toxicity testing by companies to reduce drug failures.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- Aragen Life Sciences Pvt. Ltd.
- Bio Rad Laboratories Inc.
- BioIVT LLC
- Catalent Inc.
- Charles River Laboratories International Inc.
- Creative Bioarray
- Creative Biolabs
- Eurofins Scientific SE
- Evotec SE
- Gentronix Ltd.
- InSphero AG
- Laboratory Corp. of America Holdings
- MB Research Labs
- Merck KGaA
- Promega Corp.
- SGS SA
- Thermo Fisher Scientific Inc.
- XENOMETRIX AG
